Cetera Investment Advisers Anavex Life Sciences Corp. Transaction History
Cetera Investment Advisers
- $55.9 Billion
- Q2 2025
A detailed history of Cetera Investment Advisers transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Cetera Investment Advisers holds 15,822 shares of AVXL stock, worth $142,556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,822
Previous 20,059
21.12%
Holding current value
$142,556
Previous $172,000
15.7%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AVXL
# of Institutions
196Shares Held
32MCall Options Held
1.16MPut Options Held
804K-
Black Rock Inc. New York, NY6.39MShares$57.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$46 Million0.0% of portfolio
-
State Street Corp Boston, MA2.95MShares$26.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.02MShares$18.2 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1.02MShares$9.23 Million0.83% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $702M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...